Stock UniverseDerived research view · source repositories remain read-only

Standard BioTools Inc. (LAB)

Life Science Tools / Diagnostics / MedTech · Healthcare / Medical Devices
Score Band
Speculative
Selection Score
27.24
Global Rank
2454
Market Cap
434.56M
Latest Close
1.15
RS Composite
-5.01% · G#1737

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
18.56%
3M
16.16%
6M
-20.14%
1Y
6.48%
3Y
-51.06%
5Y
-80.17%
10Y
-88.31%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 3.50M · 30-day average: 2.40M · Max drawdown over stored range: -93.87%

Research Snapshot

Relative Strength vs SPX

RS Composite-5.01%
20D RS14.36%
60D RS9.58%
120D RS-29.29%
Global RS Rank1737 · 48.23% percentile
Watch+Speculative RS Rank1102 · 47.45% percentile
Group ScopeWatch+Speculative
Primary RS Rank55 · 61.27% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank125 / 246
Primary Percentile49.59
Score Notesmarket-cap support, industry-tailwind, small-cap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for LAB.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue138.144130.58197.948106.34174.43285.331
Revenue Growth (YoY)17.827%-5.475%-24.991%8.568%64.032%-51.081%
Gross Profit46.86531.42937.05150.4584.26242.543
Operating Income-51.036-67.459-99.09-63.039-134.757-93.305
Free Cash Flow-28.134-57.325-93.195-46.118-151.809-82.653
Free Cash Flow Per Share-0.391-0.756-1.19-0.583-0.43-0.217
EPS (Diluted) GAAP-0.735939-0.781635-2.427661-0.943102-0.523429-0.196256
EPS Growth
EPS Non-GAAP
Gross Margin33.925%24.069%37.827%47.442%48.307%49.856%
Operating Margin-36.944%-51.661%-101.166%-59.281%-77.255%-109.345%
Profit Margin-38.38%-45.364%-194.081%-70.205%-106.001%-87.771%
Free Cash Flow Margin-20.366%-43.9%-95.147%-43.368%-87.03%-96.862%
Shares Outstanding (Diluted)72.04475.78678.30579.16353.245381.623
Shares Change (YoY)7.884%5.194%3.324%1.092%346.242%8.034%

SEC Quarterly Fundamentals

No processed quarterly rows for LAB.